Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection

The Platelet to lymphocyte ratio (PLR) has been reported to predict prognosis of patients with hepatocellular carcinoma (HCC). This study examined the prognostic potential of stratified PLR for HCC patients undergoing curative liver resection. Medical records were retrospectively analyzed for 778 HC...

Full description

Saved in:
Bibliographic Details
Main Authors: Hao-Jie Yang, Jing-Hang Jiang, Qing-An Liu, Cheng-Mao Zhou, Yang-feng Du, Tao Wu, Neng-Zhi Chen, Bang-De Xiang
Format: Article
Language:English
Published: SAGE Publishing 2017-06-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317707375
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849396629863399424
author Hao-Jie Yang
Jing-Hang Jiang
Qing-An Liu
Cheng-Mao Zhou
Yang-feng Du
Tao Wu
Neng-Zhi Chen
Bang-De Xiang
author_facet Hao-Jie Yang
Jing-Hang Jiang
Qing-An Liu
Cheng-Mao Zhou
Yang-feng Du
Tao Wu
Neng-Zhi Chen
Bang-De Xiang
author_sort Hao-Jie Yang
collection DOAJ
description The Platelet to lymphocyte ratio (PLR) has been reported to predict prognosis of patients with hepatocellular carcinoma (HCC). This study examined the prognostic potential of stratified PLR for HCC patients undergoing curative liver resection. Medical records were retrospectively analyzed for 778 HCC patients undergoing curative liver resection at the Affiliated Tumor Hospital of Guangxi Medical University and the First People’s Hospital of Changde between April 2010 and October 2013. Patients were stratified based on quintile analysis of their preoperative PLR, and patients in different quintiles were analyzed for overall survival (OS) and disease-free survival (DFS) using Kaplan-Meier analysis. Independent predictors of death or recurrence were explored using multivariable Cox proportional hazard regression. Higher PLR quintiles were significantly associated with poorer overall survival (p < 0.001). Multivariate analysis showed PLR to be an independent risk factor for OS (p = 0.003). Patients in PLR quintile 5 had lower overall survival than in quintile 1 (hazard ratio (HR) = 2.780, 95% confidence interval (CI): 1.769–4.367, p < 0.001). Although patients in PLR quintile 5 had significantly lower disease-free survival (DFS) than in quintile 1 (HR = 1.534, 95% CI: 1.112–2.117, p = 0.009), this association was not significant after multivariable adjustment (p = 0.220). Subgroup analysis also showed that PLR quintiles were significantly associated with poor OS in patients positive for HBsAg or with cirrhosis (both p < 0.001). Similar results were obtained when PLR was analyzed as a dichotomous variable with cut-off values of 110 and 115. Elevated preoperative PLR may be independently associated with poor OS and DFS in HCC patients following curative resection.
format Article
id doaj-art-d1685f78495e403e8254ce2df8ac757e
institution Kabale University
issn 1423-0380
language English
publishDate 2017-06-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-d1685f78495e403e8254ce2df8ac757e2025-08-20T03:39:17ZengSAGE PublishingTumor Biology1423-03802017-06-013910.1177/1010428317707375Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resectionHao-Jie Yang0Jing-Hang Jiang1Qing-An Liu2Cheng-Mao Zhou3Yang-feng Du4Tao Wu5Neng-Zhi Chen6Bang-De Xiang7Department of General Surgery, The First People’s Hospital of Changde, Changde, ChinaDepartment of General Surgery, The Second People’s Hospital of Jing Men, Jingmen, ChinaDepartment of General Surgery, The First People’s Hospital of Changde, Changde, ChinaDepartment of Anesthesiology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, ChinaDepartment of Oncology, The First People’s Hospital of Changde, Changde, ChinaDepartment of Oncology, The First People’s Hospital of Changde, Changde, ChinaDepartment of General Surgery, The First People’s Hospital of Changde, Changde, ChinaDepartment of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, ChinaThe Platelet to lymphocyte ratio (PLR) has been reported to predict prognosis of patients with hepatocellular carcinoma (HCC). This study examined the prognostic potential of stratified PLR for HCC patients undergoing curative liver resection. Medical records were retrospectively analyzed for 778 HCC patients undergoing curative liver resection at the Affiliated Tumor Hospital of Guangxi Medical University and the First People’s Hospital of Changde between April 2010 and October 2013. Patients were stratified based on quintile analysis of their preoperative PLR, and patients in different quintiles were analyzed for overall survival (OS) and disease-free survival (DFS) using Kaplan-Meier analysis. Independent predictors of death or recurrence were explored using multivariable Cox proportional hazard regression. Higher PLR quintiles were significantly associated with poorer overall survival (p < 0.001). Multivariate analysis showed PLR to be an independent risk factor for OS (p = 0.003). Patients in PLR quintile 5 had lower overall survival than in quintile 1 (hazard ratio (HR) = 2.780, 95% confidence interval (CI): 1.769–4.367, p < 0.001). Although patients in PLR quintile 5 had significantly lower disease-free survival (DFS) than in quintile 1 (HR = 1.534, 95% CI: 1.112–2.117, p = 0.009), this association was not significant after multivariable adjustment (p = 0.220). Subgroup analysis also showed that PLR quintiles were significantly associated with poor OS in patients positive for HBsAg or with cirrhosis (both p < 0.001). Similar results were obtained when PLR was analyzed as a dichotomous variable with cut-off values of 110 and 115. Elevated preoperative PLR may be independently associated with poor OS and DFS in HCC patients following curative resection.https://doi.org/10.1177/1010428317707375
spellingShingle Hao-Jie Yang
Jing-Hang Jiang
Qing-An Liu
Cheng-Mao Zhou
Yang-feng Du
Tao Wu
Neng-Zhi Chen
Bang-De Xiang
Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection
Tumor Biology
title Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection
title_full Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection
title_fullStr Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection
title_full_unstemmed Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection
title_short Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection
title_sort preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection
url https://doi.org/10.1177/1010428317707375
work_keys_str_mv AT haojieyang preoperativeplatelettolymphocyteratioisavaluableprognosticbiomarkerinpatientswithhepatocellularcarcinomaundergoingcurativeliverresection
AT jinghangjiang preoperativeplatelettolymphocyteratioisavaluableprognosticbiomarkerinpatientswithhepatocellularcarcinomaundergoingcurativeliverresection
AT qinganliu preoperativeplatelettolymphocyteratioisavaluableprognosticbiomarkerinpatientswithhepatocellularcarcinomaundergoingcurativeliverresection
AT chengmaozhou preoperativeplatelettolymphocyteratioisavaluableprognosticbiomarkerinpatientswithhepatocellularcarcinomaundergoingcurativeliverresection
AT yangfengdu preoperativeplatelettolymphocyteratioisavaluableprognosticbiomarkerinpatientswithhepatocellularcarcinomaundergoingcurativeliverresection
AT taowu preoperativeplatelettolymphocyteratioisavaluableprognosticbiomarkerinpatientswithhepatocellularcarcinomaundergoingcurativeliverresection
AT nengzhichen preoperativeplatelettolymphocyteratioisavaluableprognosticbiomarkerinpatientswithhepatocellularcarcinomaundergoingcurativeliverresection
AT bangdexiang preoperativeplatelettolymphocyteratioisavaluableprognosticbiomarkerinpatientswithhepatocellularcarcinomaundergoingcurativeliverresection